In two separate decisions involving the same parties, the Federal Circuit affirmed the PTAB’s determination that claims challenged in a CBM proceeding are eligible for CBM review and are unpatentable under 35 U.S.C. § 101. A patent is eligible for CBM review if it “claims a method or corresponding apparatus for performing data processing or other operations used in the practice, administration, or management of a ﬁnancial product or service, except that the term does not include patents for technological inventions." In its opinions, the Court elaborated on the “technological invention” exception to CBM review.
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.